osimertinib
astrazeneca
['osimertinib', 'adaura', 'nsclc', 'sclc', 'aura ,(-laura)']
osimertinib is a fantastic treatment option in egfrm nsclc, but adaura #asco23 study may have some flaws. patients participating in clinical studies should pay attention to #crossover of the control arm, once progressed. be informed of the study design! 
🇭🇷🇺🇸